Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pain medicine (Malden, Mass.)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1526-4637.2006.00085.XPMID 16533193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoid receptors and pain following peripheral nerve injury.

  2004cited by this paper
• A single dose study of nabilone, a synthetic cannabinoid

  2004cited by this paper
• Cannabis use for chronic non‐cancer pain: results of a prospective survey

  2003cited by this paper
• Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

  2003cited by this paper
• Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.

  2003cited by this paper
• A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

  2003cited by this paper
• Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

  2002cited by this paper
• Cannabinoid analgesia.

  2002cited by this paper
• The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

  2001cited by this paper
• Cannabinoid receptors and pain.

  2001cited by this paper
• Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

  1999cited by this paper
• An analgesia circuit activated by cannabinoids

  1998cited by this paper
• CANNABIS AND CANNABINOIDS IN PAIN RELIEF

  1998cited by this paper
• Prevalence of chronic benign pain disorder among adults: a review of the literature

  1998cited by this paper
• Cannabinoid transmission and pain perception.

  1998cited by this paper
• What cost chronic pain?

  1996cited by this paper
• Pharmacokinetics, metabolism and drug-abuse potential of nabilone.

  1982cited by this paper
• The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety

  1981cited by this paper
• Single‐Dose Study of Nabilone in Anxious Volunteers

  1981cited by this paper
• Effeets of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns

  1976cited by this paper
• Effects of high dosage delta‐9‐tetrahydrocannabinol on sleep patterns in man

  1975cited by this paper
• Clinical pharmacology of nabilone, a cannabinol derivative

  1975cited by this paper
• (-) Delta 9 THC as an hypnotic. An experimental study of three dose levels.

  1973cited by this paper

• Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility

  2025cites this paper
• Neurologists’ perspectives of cannabis-based medicines: results from an all-Ireland survey

  2025cites this paper
• Efficiency of cannabis and cannabidiol in managing chronic pain syndromes: A comprehensive narrative review.

  2024cites this paper
• Pain Medications Used by Persons Living With Fibromyalgia: A Comparison Between the Profile of a Quebec Sample and Clinical Practice Guidelines

  2023cites this paper
• Gender Differences in Medication Adverse Effects Experienced by People Living With Chronic Pain

  2022cites this paper
• [Use of dronabinol in the treatment of resistant neuropathic pain: Feedback from patients followed in a multidisciplinary pain center].

  2022cites this paper
• Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain.

  2021cites this paper
• Cannabidiol modulation of oxidative stress and signalling

  2021cites this paper
• Prospects for the Use of Cannabinoids in Psychiatric Disorders

  2021cites this paper
• Validity of Algorithms for Identification of Individuals Suffering from Chronic Noncancer Pain in Administrative Databases: A Systematic Review

  2020cites this paper
• Marijuana, lower urinary tract symptoms, and pain in the urologic patient.

  2020cites this paper
• Medical Marijuana and Other Cannabinoids

  2020cites this paper
• Cannabinoids in urology. Which benign conditions might they be appropriate to treat: A systematic review.

  2020cites this paper
• Use of a synthetic cannabinoid (nabilone) in the ongoing management of posttraumatic stress disorder nightmares in the Canadian Armed Forces: Results of an anonymous online survey

  2020cites this paper
• It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets

  2020cites this paper
• Cannabis and Cannabis Use Disorders

  2019cites this paper
• Pharmacologic targeting of the CB2 cannabinoid receptor for application in centrally-mediated chronic pain

  2019cites this paper
• Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018

  2019cites this paper
• Spontaneous, anecdotal, retrospective, open‐label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan)

  2019cites this paper
• Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

  2018cites this paper
• Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

  2018cites this paper
• Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

  2018cites this paper
• Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

  2018cites this paper
• The Cannabinoids as Therapeutic Agents in the Management of Pain

  2017cites this paper
• 4 Cannabinoids and Neuropathic Pain

  2017cites this paper
• The central cannabinoid receptor type-2 (CB2) and chronic pain

  2017cites this paper
• Chapter 85 – The Synthetic Analog of Δ9-Tetrahydrocannabinol (THC): Nabilone. Pharmacology and Clinical Application

  2017cites this paper
• Are cannabinoids an effective treatment for chronic non-cancer pain?

  2017cites this paper
• Cannabinoid derivatives and the pharmacological management of pain

  2016cites this paper
• Nabilone for the Management of Pain

  2016cites this paper
• The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study

  2016cites this paper
• Journal of Sleep Disorders & Therapy

  2015cites this paper
• Review Article: Sleep, Pain and Cannabis

  2015cites this paper
• The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity

  2015cites this paper
• of Medicinal Marijuana , Cannabinoids , and Therapeutic Implications in Medicine and Headache : What a Long Strange Trip It ’ s

  2015cites this paper
• Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

  2015cites this paper
• Market Failure in the Diffusion of User Innovations: The Case of 'Off-Label' Innovations by Medical Clinicians

  2014cites this paper
• Cannabinoids in the management of dif cult to treat pain

  2014cites this paper
• Cannabinoids and the brain: New hopes for new therapies

  2014cites this paper
• A double-blind placebo control pilot study on the safety and tolerability of Nabilone in marijuana users

  2013cites this paper
• The use of cannabinoids in chronic pain

  2013cites this paper
• Role of Cannabinoids in Pain Management

  2013cites this paper
• WHO Ladder—Relevance in Today's World

  2013cites this paper
• Management of Fibromyalgia Syndrome: Review of Evidence

  2013cites this paper
• Neuropathic Pain

  2013cites this paper
• Chemical constituents and biological activity of medicinal plants used for the management of sickle cell disease - A review

  2013cites this paper
• Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.

  2012cites this paper
• An enriched‐enrolment, randomized withdrawal, flexible‐dose, double‐blind, placebo‐controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

  2012cites this paper
• Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Discovery in Lepidium meyenii (Maca) Extracts.

  2012cites this paper
• Cannabinoids and Neuropathic Pain

  2012cites this paper
• Lack of effect of central nervous system‐active doses of nabilone on capsaicin‐induced pain and hyperalgesia

  2012cites this paper
• The cannabinoid CB2 receptor as a target for the treatment of neuropathic pain

  2012cites this paper
• Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?

  2012cites this paper
• Recent Advances in the Pharmacological Management of Pain

  2012cites this paper
• Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids

  2011influential citation
• Role of the Endocannabinoid System in Anxiety and Stress-Related Disorders

  2011influential citation
• An Open‐Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy

  2011cites this paper
• Nonopioid Analgesics in Pain Management

  2011cites this paper
• Case Study: Management of Post- Parotidectomy Neuropathic Pain with Tetrahydrocannabinol:cannabidiol (Sativex)

  2011cites this paper
• Cannabinoid mediated diuresis in mice

  2011cites this paper
• L’échelle analgésique de l’OMS convient-elle toujours?

  2010cites this paper
• Cannabis use in palliative care - an examination of the evidence and the implications for nurses.

  2010cites this paper
• CB(1) cannabinoid receptors and their associated proteins.

  2010cites this paper
• Functional role of cannabinoid receptors in urinary bladder

  2010cites this paper
• Using cannabinoids in pain and palliative care.

  2010cites this paper
• Examining the roles of cannabinoids in pain and other therapeutic indications: a review

  2010cites this paper
• Is the WHO analgesic ladder still valid? Twenty-four years of experience.

  2010cites this paper
• The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial

  2010cites this paper
• Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside

  2009cites this paper
• Cannabinoids in pain and palliative care medicine – hope or dope?

  2009cites this paper
• Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.

  2009cites this paper
• Do cannabinoids have a role in cancer pain management?

  2009cites this paper
• The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)

  2009cites this paper
• A treatment algorithm for neuropathic pain: an update.

  2009cites this paper
• Fungal biotransformation of cannabinoids: potential for new effective drugs.

  2009cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2009cites this paper
• Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.

  2008cites this paper
• Cannabinoids in chronic pain and palliative care.

  2008cites this paper
• Uso de Canabinóides na Dor Crônica e em Cuidados Paliativos* Cannabinoids in Chronic Pain and Palliative Care

  2008cites this paper
• A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

  2008cites this paper
• Cannabinoids in the management of difficult to treat pain

  2008cites this paper
• Cannabinoids for the treatment of neuropathic pain: clinical evidence.

  2008cites this paper
• Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

  2008cites this paper
• Uso de canabinoides en el dolor crónico y en cuidados paliativos

  2008cites this paper
• The Future of Cannabinoids as Analgesic Agents: A Pharmacologic, Pharmacokinetic, and Pharmacodynamic Overview

  2007cites this paper
• Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.

  2007cites this paper
• Cannabinoids

  2007cites this paper
• Cannabis; adverse effects from an oromucosal spray

  2007cites this paper
• Epstein-Barr virus latent membrane protein 2A and autoimmunity.

  2007cites this paper
• Cannabinoids in health and disease

  2007cites this paper
• Laser literature watch.

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper